A new drug, Voranigo, slows the progression of brain tumors

For more cancer coverage, sign up for STAT’s pop-up newsletter, focusing on this weekend’s European Society for Medical Oncology conference, one of the biggest oncology meetings of the year. Details here.

When Rachel Guberman found out she had brain cancer, she read and Googled so much about the disease that she joked she had reached the end of the Internet.

But she avoided delving into one specific topic: what she might have to endure with chemotherapy and radiation.